inflammatory cells in retina

[frodo]

Metrics, distribution and dynamics of inflammatory cells in in vivo retina during multiple sclerosis

https://www.medrxiv.org/content/10.1101 ... 25325926v1

Abstract

Purpose: To detect in vivo retinal cellular biomarkers of inflammation in multiple sclerosis (MS), in particular immune cellular infiltrates, with a specific focus on determining whether retinal inflammation is detectable beyond episodes of acute optic neuritis (ON).

Design: Prospective cohort and longitudinal study Participants: Fifty-one MS patients included from two studies ONSTIM (ClinicalTrials.gov, ID:NCT04042363) and Retimus (ClinicalTrials.gov, ID:NCT04289909), with different phenotypes: relapsing-remitting MS (RMS) with recent optic neuritis (ON) (N=31), RMS without recent ON (N=12), and progressive MS (N=8), alongside nine healthy controls.

Methods: Ophthalmic and neurological examinations were performed at each visit. All participants underwent label-free cellular resolution imaging of the retina using Phase contrast Adaptive Optics Scanning Laser Ophthalmoscope (AOSLO). Imaging was repeated at 3, 6 and 12 months to monitor changes over time.

Main Outcome Measures: Visual outcomes measures using high-contrast visual acuity (ETDRS) and low-contrast visual acuity (Sloan, 2.5%). Eye fundus images and Optical Coherence Tomography (OCT) cross-sections, and Magnetic Resonance Imaging (MRI) including brain sequences (3D FLAIR, 3D DIR, T1+gadolinium) and orbital sequences (3D DIR on orbits, 2D proton density, T1 DANTE+gadolinium). Metrics such as lesion location (intra-orbital, canalicular, cisternal, or chiasma), lesion length, and the distance between the papilla and the lesion (for intraorbital lesions) obtained from manually segmentation of optic nerve lesions. Morphometrics of cellular infiltrates from AOSLO images such as cell density, mean size, and percentage of affected patients.

Results: We identified immune infiltrates for the first time, likely lymphocytes and microglial cells, in the retinal ganglion cell layer, with the highest densities observed in ON-RMS patients (93.6%). These cells were sometimes detected weeks before clinical ON onset, and their density declined post-ON, though at varying rates. Infiltrates were more frequently found in MS patients than in controls, even outside acute ON episodes. The cells of a mean size of 12.0 ± 4.2 µm showed minimal movement and often interacted with vessels, suggesting migratory behavior.

Conclusions: Our results suggest that AOSLO imaging can detect subtle retinal inflammatory changes not captured by conventional clinical systems, offering a promising tool for monitoring neuroinflammation in MS and other neurodegenerative diseases.